/

Other

/

Cycle Pharmaceuticals

Cycle Pharmaceuticals

Cycle Pharmaceuticals

Verified Nov 2026

Other

·

United Kingdom flag

Cambridge, England

·

Since 2012

Cycle Pharmaceuticals is a privately-held biotechnology company headquartered in Cambridge, England, founded in 2012, with 100–200 employees and estimated revenue of $10–50M. It develops treatments for rare genetic diseases including metabolic, neurological, and immunological conditions across medical and related sectors. The company launched CAVHANZA (nilotinib) in the United States in August 2026 and completed acquisition of Applied Therapeutics in February 2026.

Cycle Pharmaceuticals

Verified Nov 2026

AT A GLANCE

Founded

2012

Headquarters

United Kingdom flag

Cambridge, England

Employees

100-200

Ownership

Cycle Pharmaceuticals at a glance

Revenue

$10-50M

Est. band

Employees

100-200

Founded

2012

Headquarters

Cambridge, England

Industries

Automotive

Electric Vehicles

Medical

Overview

Cycle Pharmaceuticals is a privately-held biotechnology company headquartered in Cambridge, England, founded in 2012, with 100–200 employees and estimated revenue of $10–50M. It develops treatments for rare genetic diseases including metabolic, neurological, and immunological conditions across medical and related sectors. The company launched CAVHANZA (nilotinib) in the United States in August 2026 and completed acquisition of Applied Therapeutics in February 2026.

At a glance

Attribute

Detail

Founded

2012

Headquarters

Cambridge, England

Employees

100-200

Revenue

$10-50M (estimated)

What Cycle Pharmaceuticals makes

The company specializes in orphan drug development, drug repurposing, and generic formulations, with a portfolio addressing conditions such as phenylketonuria, tyrosinemia, alkaptonuria, and multiple sclerosis.

Products and capabilities described on the company's own site include Pump (source: cyclepharma.com).

Latest developments

Facilities

Cycle Pharmaceuticals is headquartered in Cambridge, England. Public sources also reference these locations:

Company details

Cycle Pharmaceuticals operates with a patient-centric model offering free medications in countries unable to afford them and provides comprehensive patient support including dietary supplements and personalized care. Cycle Pharmaceuticals was founded in 2012, has an estimated 100-200 employees, and is headquartered in Cambridge, England.

Frequently asked questions

What does Cycle Pharmaceuticals do?

Cycle Pharmaceuticals is a privately-held biotechnology company headquartered in Cambridge, England, founded in 2012, with 100–200 employees and estimated revenue of $10–50M. It develops treatments for rare genetic diseases including metabolic, neurological, and immunological conditions across medical and related sectors. The company launched CAVHANZA (nilotinib) in the United States in August 2026 and completed acquisition of Applied Therapeutics in February 2026.

Where is Cycle Pharmaceuticals headquartered?

Cycle Pharmaceuticals is headquartered in Cambridge, England (J J Thomson Avenue, Cambridge, England, CB3 0).

When was Cycle Pharmaceuticals founded?

Cycle Pharmaceuticals was founded in 2012.

How big is Cycle Pharmaceuticals?

Cycle Pharmaceuticals has an estimated 100-200 employees, with revenue in the $10-50M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Cambridge, England (HQ)Headquarters · United Kingdom
Cambridge, England (HQ)J J Thomson Avenue, Cambridge, England, CB3 0, United KingdomHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.